{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:19:00Z","timestamp":1792509540556,"version":"4.5.0"},"reference-count":52,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2016,5,17]],"date-time":"2016-05-17T00:00:00Z","timestamp":1463443200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012680","name":"University Medical Center Hamburg-Eppendorf","doi-asserted-by":"crossref","award":["NWF-14\/06"],"award-info":[{"award-number":["NWF-14\/06"]}],"id":[{"id":"10.13039\/501100012680","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0153380","type":"journal-article","created":{"date-parts":[[2016,5,17]],"date-time":"2016-05-17T17:51:31Z","timestamp":1463507491000},"page":"e0153380","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":46,"title":["Comparative Safety of Pharmacologic Treatments for Persistent Depressive Disorder: A Systematic Review and Network Meta-Analysis"],"prefix":"10.1371","volume":"11","author":[{"given":"Ramona","family":"Meister","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessa","family":"von Wolff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannes","family":"Mohr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"H\u00e4rter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Nestoriuc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"H\u00f6lzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Levente","family":"Kriston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,5,17]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1001\/archpsyc.62.6.593","article-title":"Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the national comorbidity survey replication","volume":"62","author":"RC Kessler","year":"2005","journal-title":"Arch Gen Psychiatry"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1177\/0963721410366007","article-title":"Chronic depression: diagnosis and classification","volume":"19","author":"DN Klein","year":"2010","journal-title":"Curr Dir Psychol Sci"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1007\/s11920-008-0074-6","article-title":"Chronic depression: update on classification and treatment","volume":"10","author":"DC Torpey","year":"2008","journal-title":"Curr Psychiatry Rep"},{"key":"ref4","article-title":"Diagnostic and statistical manual of mental disorders","year":"2013"},{"key":"ref5","first-page":"CD001130","article-title":"Drugs versus placebo for dysthymia","volume":"2","author":"MS De Lima","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"ref6","first-page":"CD004047","article-title":"A comparison of active drugs for the treatment of dysthymia","author":"MS De Lima","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"ref7","first-page":"73","article-title":"Continuation treatment of chronic depression: a comparison of nefazodone, cognitive behavioral analysis system of psychotherapy, and their combination","volume":"37","author":"JH Kocsis","year":"2003","journal-title":"Psychopharmacol Bull"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1177\/070674370204700705","article-title":"Breaking the myths: new treatment approaches for chronic depression","volume":"47","author":"EE Michalak","year":"2002","journal-title":"Can J Psychiatry"},{"key":"ref9","article-title":"Practice guideline for the treatment of patients with major depressive disorder","year":"2010"},{"key":"ref10","unstructured":"DGPPN, B\u00c4K, KBV, AWMF, Akd\u00c4, BPtK, et al. (eds) for the Leitliniengruppe Unipolare Depression. S3-Leitlinie\/Nationale VersorgungsLeitlinie Unipolare Depression Langfassung, 2. Auflage, Vers 1.2015. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.depression.versorgungsleitlinien.de\" xlink:type=\"simple\">www.depression.versorgungsleitlinien.de<\/ext-link>; [cited: 12.04.2016]; <comment>doi: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/dx.doi.org\/10.6101\/AZQ\/000262\" xlink:type=\"simple\">10.6101\/AZQ\/000262<\/ext-link><\/comment>"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/da.22236","article-title":"Efficacy and acceptability of acute treatments for persistent depressive disorder: a network meta-analysis","volume":"31","author":"L Kriston","year":"2014","journal-title":"Depress Anxiety"},{"key":"ref12","article-title":"National Clinical Practice Guideline 90","year":"2009"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jad.2012.06.007","article-title":"Selective serotonin reuptake inhibitors and tricyclic antidepressants in the acute treatment of chronic depression and dysthymia: a systematic review and meta-analysis","volume":"144","author":"A Von Wolff","year":"2013","journal-title":"J Affect Disord"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/da.22236","article-title":"Efficacy and acceptability of acute treatments for persistent depressive disorder: a network meta-analysis","volume":"31","author":"L Kriston","year":"2014","journal-title":"Depress Anxiety"},{"key":"ref15","article-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0","author":"JP Higgins","year":"2011"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"772","DOI":"10.7326\/0003-4819-155-11-201112060-00009","article-title":"Comparative Benefits and Harms of Second-Generation Antidepressants for Treating Major Depressive Disorder\u2014An Updated Meta-analysis","volume":"155","author":"G Gartlehner","year":"2013","journal-title":"Ann Intern Med"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"e16718","DOI":"10.1371\/journal.pone.0016718","article-title":"Adverse event assessment of antimuscarinics for treating overactive bladder: a network meta-analytic approach","volume":"6","author":"TM Kessler","year":"2011","journal-title":"PLoS One"},{"key":"ref18","first-page":"1245","article-title":"Adverse effects associated with selective serotonin reuptake inhibitors and tricyclic antidepressants: a meta-analysis","volume":"159","author":"E Trindade","year":"1998","journal-title":"Can Med Assoc J"},{"issue":"Suppl 1","key":"ref19","first-page":"S39","article-title":"Severe adverse drug reactions of antidepressants: results of the German multicenter drug surveillance program AMSP","volume":"37","author":"D Degner","year":"2004","journal-title":"Pharmacopsychiatry"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1055\/s-2005-837806","article-title":"Side-effect profile of fluoxetine in comparison with other SSRIs, tricyclic and newer antidepressants: a meta-analysis of clinical trial data","volume":"38","author":"P Brambilla","year":"2005","journal-title":"Pharmacopsychiatry"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1002\/gps.1156","article-title":"A comparison of side effects of selective serotonin reuptake inhibitors and tricyclic antidepressants in older depressed patients: a meta-analysis","author":"K Wilson","year":"2004","journal-title":"Int J Geriatr Psychiatry"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1517\/14656566.1.5.917","article-title":"Selective serotonin reuptake inhibitors: a review of efficacy and tolerability in depression","volume":"1","author":"S Mace","year":"2000","journal-title":"Expert Opin Pharmacother"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1098\/rstb.2010.0394","article-title":"Lessons learned from placebo groups in antidepressant trials","volume":"366","author":"M Shedden Mora","year":"2011","journal-title":"Philos Trans R Soc"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/acr.20160","article-title":"Prediction of nonspecific side effects in rheumatoid arthritis patients by beliefs about medicines","volume":"62","author":"Y Nestoriuc","year":"2010","journal-title":"Arthritis Care Res"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1001\/jama.287.5.622","article-title":"Nonspecific medication side effects and the nocebo phenomenon","volume":"287","author":"AJ Barsky","year":"2002","journal-title":"JAMA"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.euroneuro.2013.11.014","article-title":"The placebo-nocebo response: Controversies and challenges from clinical and research perspective","volume":"24","author":"M Jakovljevic","year":"2014","journal-title":"Eur Neuropsychopharmacol. Elsevier"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.comppsych.2004.10.002","article-title":"Mental health service use by patients with dysthymic disorder: treatment use and dropout in a 7 1\/2-year naturalistic follow-up study","volume":"46","author":"BR McFarland","year":"2005","journal-title":"Compr Psychiatry"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1176\/appi.ajp.157.6.931","article-title":"Five-year course and outcome of dysthymic disorder: a prospective, naturalistic follow-up study","volume":"157","author":"DN Klein","year":"2000","journal-title":"Am J Psychiatry"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/j.euroneuro.2013.05.001","article-title":"Side effects of antidepressants during long-term use in a naturalistic setting","volume":"23","author":"PM Bet","year":"2013","journal-title":"Eur Neuropsychopharmacol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1600-0447.1996.tb10664.x","article-title":"Subjective experience of treatment, side-effects, mental state and quality of life in chronic schizophrenic out-patients treated with depot neuroleptics","volume":"93","author":"EB Larsen","year":"1996","journal-title":"Acta Psychiatr Scand"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.curtheres.2005.04.006","article-title":"Antidepressant-related adverse effects impacting treatment compliance: results of a patient survey","volume":"66","author":"AK Ashton","year":"2005","journal-title":"Curr Ther Res Clin Exp"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/00004850-199400910-00008","article-title":"Selective serotonin reuptake inhibitora: meta-analysis of discontinuation rates","volume":"9","author":"SA Montgomery","year":"1994","journal-title":"Int Clin Psychopharmacol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/M14-2385","article-title":"The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations","volume":"162","author":"B Hutton","year":"2015","journal-title":"Ann Intern Med"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/1471-244X-10-95","article-title":"Effectiveness of psychotherapeutic, pharmacological, and combined treatments for chronic depression: a systematic review (METACHRON)","volume":"10","author":"L Kriston","year":"2010","journal-title":"BMC Psychiatry"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.jclinepi.2008.06.007","article-title":"AHRQ series paper 4: assessing harms when comparing medical interventions: AHRQ and the effective health-care program","volume":"63","author":"R Chou","year":"2010","journal-title":"J Clin Epidemiol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1586\/14737167.2.4.367","article-title":"Meta-analysis of rare and adverse event data","volume":"2","author":"AJ Sutton","year":"2002","journal-title":"Expert Rev Pharmacoeconomics Outcomes Res"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1080\/03610919608813357","article-title":"An assessment of the use of the continuity correction for sparse data in meta-analysis","volume":"25","author":"SS Sankey","year":"1996","journal-title":"Commun Stat\u2014Simul Comput"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/jrsm.1058","article-title":"Network meta-analysis, electrical networks and graph theory","volume":"3","author":"G R\u00fccker","year":"2012","journal-title":"Res Synth Methods"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1471-2288-13-35","article-title":"A graphical tool for locating inconsistency in network meta-analyses","volume":"13","author":"U Krahn","year":"2013","journal-title":"BMC Med Res Methodol"},{"key":"ref40","unstructured":"R\u00fccker G, Schwarzer G, Krahn U, K\u00f6nig J. netmeta: Network meta-analysis with R. 2014. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/cran.r-project.org\/web\/packages\/netmeta\/netmeta.pdf\" xlink:type=\"simple\">http:\/\/cran.r-project.org\/web\/packages\/netmeta\/netmeta.pdf<\/ext-link>"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"R DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"ref42","unstructured":"R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria; 2009."},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v036.i03","article-title":"Conducting meta-analyses in R with the metafor package","volume":"36","author":"W Viechtbauer","year":"2010","journal-title":"J Stat Softw"},{"key":"ref44","unstructured":"Viechtbauer W. metafor: meta-analysis package for R. 2014. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/cran.r-project.org\/web\/packages\/metafor\/metafor.pdf\" xlink:type=\"simple\">http:\/\/cran.r-project.org\/web\/packages\/metafor\/metafor.pdf<\/ext-link>"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"135s","DOI":"10.1016\/0924-9338(96)85188-1","article-title":"Atypical antipsychotic drugs in dysthymia: placebo controlled studies of amisulpride versus imipramine, versus amineptine","volume":"11","author":"P Boyer","year":"1996","journal-title":"Eur Psychiatry"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000026556","article-title":"Amisulpride versus amineptine and placebo for the treatment of dysthymia","volume":"39","author":"P Boyer","year":"1999","journal-title":"Neuropsychobiology"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0165-0327(96)00103-6","article-title":"Amisulpride versus imipramine and placebo in dysthymia and major depression","volume":"43","author":"Y Lecrubier","year":"1997","journal-title":"J Affect Disord"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/YCO.0000000000000022","article-title":"The re-labelling of dysthymic disorder to persistent depressive disorder in DSM-5: old wine in new bottles?","volume":"27","author":"D Rhebergen","year":"2014","journal-title":"Curr Opin Psychiatry"},{"key":"ref49","article-title":"Adverse event methods were heterogeneous and insufficiently reported in randomized trials on persistent depressive disorder","author":"R Meister","journal-title":"J Clin Epidemiol. in press"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jad.2006.06.017","article-title":"Dropouts versus completers among chronically depressed outpatients","volume":"97","author":"BA Arnow","year":"2007","journal-title":"J Affect Disord"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/01.yco.0000165594.60434.84","article-title":"The diagnosis and management of benzodiazepine dependence","volume":"18","author":"H Ashton","year":"2005","journal-title":"Curr Opin Psychiatry"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"781","DOI":"10.7326\/0003-4819-141-10-200411160-00009","article-title":"Improving patient care better reporting of harms in randomized trials: an extension of the CONSORT statement","volume":"141","author":"J Ioannidis","year":"2004","journal-title":"Ann Intern Med"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0153380","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T21:18:19Z","timestamp":1589663899000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0153380"}},"subtitle":[],"editor":[{"given":"Michel","family":"Baudry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,5,17]]},"references-count":52,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2016,5,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0153380","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,17]]}}}